(Q37990549)

26 August 2017

Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies (English)

1 reference

stem cell transplantation

26 August 2017

1 reference

Robert Chiesa

1

1 reference

PubMed ID

22390490

26 August 2017

Paul Veys

series ordinal

2

1 reference

26 August 2017

1 March 2012

1 reference

Expert Review of Clinical Immunology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

3

1 reference

26 August 2017

255-66; quiz 267

1 reference

Stem cell transplantation with reduced-intensity conditioning regimens: a review of ten years experience with new transplant concepts and new therapeutic agents

26 August 2017

1 reference

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus

21 January 2018

1 reference

Nonmyeloablative hematopoietic cell transplant for treatment of immune deficiency

21 January 2018

1 reference

Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases

21 January 2018

1 reference

Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning

21 January 2018

1 reference

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

21 January 2018

1 reference

A novel reduced-intensity stem cell transplant regimen for nonmalignant disorders

21 January 2018

1 reference

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study

21 January 2018

1 reference

188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study

21 January 2018

1 reference

Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children

21 January 2018

1 reference

Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.

21 January 2018

1 reference

Increasing mixed chimerism and the risk of graft loss in children undergoing allogeneic hematopoietic stem cell transplantation for non-malignant disorders

21 January 2018

1 reference

Treosulfan-containing regimens achieve high rates of engraftment associated with low transplant morbidity and mortality in children with non-malignant disease and significant co-morbidities.

21 January 2018

1 reference

Treosulfan-based conditioning before hematopoietic SCT: more than a BU look-alike

21 January 2018

1 reference

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Dose-escalated treosulphan in combination with cyclophosphamide as a new preparative regimen for allogeneic haematopoietic stem cell transplantation in patients with an increased risk for regimen-related complications

21 January 2018

1 reference

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

21 January 2018

1 reference

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

21 January 2018

1 reference

21 January 2018

1 reference

Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis

21 January 2018

1 reference

The use of reduced-intensity stem cell transplantation in haemophagocytic lymphohistiocytosis and Langerhans cell histiocytosis

21 January 2018

1 reference

Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis

21 January 2018

1 reference

Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft

21 January 2018

1 reference

Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency

21 January 2018

1 reference

Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases

21 January 2018

1 reference

Reproductive capability in dogs with canine leukocyte adhesion deficiency treated with nonmyeloablative conditioning prior to allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

Successful treatment of lymphoproliferative disease complicating primary immunodeficiency/immunodysregulatory disorders with reduced-intensity allogeneic stem-cell transplantation

21 January 2018

1 reference

Radioimmunotherapy-based conditioning for hematopoietic cell transplantation in children with malignant and nonmalignant diseases

21 January 2018

1 reference

Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases

21 January 2018

1 reference

Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.12.9

1 reference

release_4rkfgwlkgrggldmnbmx477pp7i

26 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4rkfgwlkgrggldmnbmx477pp7i

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

22390490

1 reference

PubMed ID

22390490